comparemela.com

Latest Breaking News On - Jubilant pharmova - Page 25 : comparemela.com

SGX Nifty up 162 points: Asian stocks, crude prices, dollar movement, Q4 earnings & more

Jubilant Pharmova Ltd Q4FY23 consolidated loss widens to Rs 97 84 crores

The Board of Directors of Jubilant Pharmova Limited, at its meeting held today have approved the financial results of the company for the period ended March 31, 2023 - Q4FY23 and FY2023.

Trade setup for Monday: Top 15 things to know before the opening bell

The short-term outlook remains robust. If the Nifty moves above 18,350, it can rise to 18,600. If the index drops below 18,350, traders should exit long positions, analysts say

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.